PT-16 cell line (high grade serous ovarian carcinoma)
PT-16 cell line (high-grade serous ovarian carcinoma)- M7-2203A cell line originated from a patient diagnosed with high-grade serous ovarian carcinoma (HGSOC). The cell line was derived from a...
Read moreabout yeda
About UsYeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education.
Spinoffs
All SpinoffsCell Source
Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company's patented Veto Cell technology enables safe and selective tuning of immune responses.
news & events
All News-
Thursday, August 15, 2024
An achievement for Israeli academia: three universities among the 100 best in the world
-
Wednesday, August 7, 2024
The 20 most promising Israeli startups for 2024 : NewMoo and Quantum Art
-
Monday, July 22, 2024
Yeda Newsletter - July 2024
-
Thursday, July 4, 2024
The Israeli company that conquers the agriculture industry.
-
Thursday, June 6, 2024
UltraSight and Mayo Clinic join forces for AI-driven cardiac care
-
Sunday, March 10, 2024
Tracells Emerges as a Pioneer in Gastrointestinal Diagnostics and Therapeutics
-
Monday, February 19, 2024
Exciting News in Insect Agriculture!
-
Tuesday, February 6, 2024
NewsLetter - January 2024
-
Thursday, January 18, 2024
Israeli institute finds new effective cancer treatment using immune cells
-
Monday, January 8, 2024
The Link Between Academia and Industry
-
Sunday, January 7, 2024
SLAM BioTherapeutics, a promising biotechnology company
-
Tuesday, November 28, 2023
The Link Between Academia and Industry (TheMarker - Hebrew Article)
-
Tuesday, July 4, 2023
Yeda's Newsletter - June 2023
-
Sunday, July 2, 2023
Exciting Breakthrough in Personalized Cancer Treatment!
-
Wednesday, June 28, 2023
ECM Dynamics
-
Sunday, June 25, 2023
Exciting news!
-
Sunday, June 11, 2023
This company is changing the way we think about computers!
-
Sunday, May 7, 2023
Move over cannabis, there's a new plant in town!
-
Thursday, April 20, 2023
Pesticides play a crucial role in preventing crop failure and ultimately
-
Wednesday, April 19, 2023
We are pleased to share the latest investment in Quantum Source Labs Ltd!!
-
Sunday, March 26, 2023
Prof. Michal Schwartz, shares her journey of finding a way to cure Alzheimer's
-
Sunday, March 26, 2023
Congratulations to Yeda’s spinoff company, Curesponse!
-
Thursday, March 9, 2023
Registration for Neurotechnology 2023 is now open!
-
Monday, March 6, 2023
Congratulations to Prof. Nir London
-
Monday, March 6, 2023
Exciting things are happening in the world of Cardiology
-
Sunday, February 26, 2023
Yeda announces partnership with eureKARE, to establish EonBio!
-
Wednesday, February 15, 2023
This Valentine’s Day, let’s take a moment to talk about Heart health. ❤️ ️
-
Tuesday, February 14, 2023
Stimulating Production and Extraction of Metabolites in Plants
-
Tuesday, February 7, 2023
Revolutionary discovery places Xinteza at the forefront of cannabinoid sourcing
-
Sunday, February 5, 2023
Meet Prof. Adi Kimchi, a principal investigator at the Molecular Genetics department.
-
Monday, January 30, 2023
The race to build the next generation of computers is on!
-
Monday, January 30, 2023
Protein comes in many shapes and forms, from meat and dairy to beans and bugs!
-
Tuesday, January 24, 2023
Decentralized low-cost emissions-free ammonia via electro catalytic reaction of water and air.
-
Thursday, January 19, 2023
IndieBio San Francisco - Batch 13 Demo Day is taking place tomorrow (January 19).
-
Thursday, January 12, 2023
Yeda's Newsletter - Jan 2023
-
Wednesday, January 11, 2023
Something exciting is happening in the world of Quantum Computing!
-
Sunday, December 25, 2022
Congratulations to the team at Curesponse
-
Thursday, December 22, 2022
Kadimastem - US $1 Million BIRD Foundation Grant
-
Wednesday, December 21, 2022
BUZZING with innovation
-
Wednesday, December 21, 2022
Happy Hanukah Prof. Boris Rybtchinski and his team
-
Sunday, December 11, 2022
Super-Resolution Using Unsupervised Deep Internal Network (No. T4-1850)
-
Wednesday, December 7, 2022
Good news for cardiac sonographers
-
Wednesday, November 30, 2022
Yeda’s Newly Established Carbon To Value Spinoff - Carbonade
-
Thursday, November 24, 2022
Joint program to make next-generation joint lubrication technology
-
Sunday, November 20, 2022
UltraSight
-
Tuesday, November 15, 2022
Metabolic Insights has signed an agreement with the RATION Consortium
-
Tuesday, November 15, 2022
לנצח את החיידק
-
Tuesday, November 15, 2022
Yeda spinoff company in C&EN's 10 Start-Ups to Watch
-
Sunday, November 6, 2022
Yeda is judging at the AgriVest Conference
-
Sunday, November 6, 2022
ClimateCrop @ COP27
-
Wednesday, November 2, 2022
Sequentify
-
Thursday, October 27, 2022
Facts and Figures 2021
-
Monday, October 24, 2022
Novel Combination Therapy For Improved Management of Depression
-
Wednesday, October 19, 2022
BIO-Europe 2022
-
Thursday, September 22, 2022
Israel’s ProFuse Technology raises $2.5M
-
Monday, September 19, 2022
Cannabinoid biosynthesis production systems
-
Sunday, September 18, 2022
Putting Liquid Biopsies on Solid Ground: Cancer Diagnosis from a Milliliter of Blood
-
Sunday, September 11, 2022
We are excited to announce that the eBeam4Therapy kick-off has already started!
-
Sunday, September 11, 2022
A Sustainable Process for Phenol Production
-
Monday, September 5, 2022
The Weizmann Institute of Science is ranked number 8 on the Leiden global ranking
-
Monday, August 29, 2022
Multimodel Transcranial Optical Vascular Assessment
-
Monday, August 29, 2022
Congratulations UltraSight,
-
Tuesday, August 23, 2022
New findings how to treat inflammatory bowel disease
-
Tuesday, August 16, 2022
A new source of cannabinoid biosynthesis
-
Tuesday, August 16, 2022
המייסדים של לייטסולבר רוצים לפתח את המחשב המהיר בעולם (ובינתיים הולך להם לא רע)
-
Wednesday, August 10, 2022
The scientist who created a mouse - Podcast
-
Wednesday, August 10, 2022
A seed investment has been made in ClimateCrop - photosynthesis enhancement Ltd, a spinoff from Yeda
-
Monday, August 8, 2022
Yeda spinoff company leveraging breakthrough stem cell technologies
-
Monday, August 8, 2022
Climate Crop is a Yeda Spinoff
-
Monday, August 1, 2022
Scan, save and share the most precious photos and memories
-
Monday, July 25, 2022
Next-generation technologies will be based on smell
-
Monday, July 25, 2022
Today Yeda's Team had the pleasure to visit the INCPM center
-
Thursday, July 21, 2022
A brilliant solution has been developed by Weizmann Institute of Science professor, Yonina Eldar
-
Wednesday, July 20, 2022
Phytolon, is emerging as an important player in the food dye market
-
Tuesday, July 5, 2022
Yeda's Newsletter - June 2022
-
Tuesday, May 24, 2022
Yeda Subsidiary Start-Ups Make Headlines Worldwide
-
Tuesday, May 3, 2022
Yeda @ Bio 2022
-
Tuesday, April 12, 2022
Lysogene Enters into an Exclusive Worldwide License Agreement with Yeda
-
Tuesday, February 8, 2022
Without Fasting and Anesthesia: The Non-Invasive Test that May Replace Colonoscopy (Hebrew)
-
Tuesday, February 8, 2022
Viruses in Service of Man - Fight Against Bacterial Diseases in Agriculture (Hebrew)
-
Tuesday, January 25, 2022
Monte Rosa Therapeutics and Yeda Announce Collaboration
-
Sunday, January 23, 2022
Yeda's Newsletter - Jan 2022
-
Wednesday, August 4, 2021
Impact NRS create Plantea Bioscience
-
Monday, May 10, 2021
Yeda - Where Science Means Business
-
Tuesday, April 27, 2021
Treating Chronic Diseases and Cancer
-
Tuesday, April 20, 2021
Hunger Switch in the Brain
-
Wednesday, March 24, 2021
Inspired by Cartilage - Liposphere
-
Monday, March 8, 2021
An interview with Yeda's CEO
-
Sunday, January 10, 2021
Planting Seeds for Better Nutrition and Sustainability
-
Sunday, January 3, 2021
Top Influencers of Maariv - 25th Place
-
Tuesday, October 6, 2020
A groundbreaking antibody treatment for Alzheimer’s disease
-
Wednesday, September 16, 2020
Israeli natural food coloring co Phytolon raises $4.1m
-
Tuesday, September 8, 2020
Greener Farming - EcoPhage
-
Tuesday, September 1, 2020
Potential Heart-Repair Protein Advances to a New Stage
-
Tuesday, August 18, 2020
A New Method for Seeing into Cells
-
Friday, August 14, 2020
Weizmann Institute’s new technology may help treat cancer
-
Thursday, August 13, 2020
COVID-19 Supports Agrifood Startups
-
Tuesday, July 14, 2020
Personalized Nutrition - DayTwo
-
Monday, July 6, 2020
Lysogene, Weizmann Institute Team Up on Gene Therapy for Neuronopathic Gaucher
-
Wednesday, June 10, 2020
Weizmann - Top 25 Universities
-
Thursday, April 23, 2020
Breaking New Ground in Head Injury Treatment
-
Wednesday, April 22, 2020
COVID-19 Research Cooperation
-
Sunday, April 19, 2020
Weizmann Race for COVID 19 Drug
-
Sunday, April 5, 2020
Stem Cells Provide COVID-19 Relief
-
Thursday, April 2, 2020
Article of the Month – Top TTO Challenges
-
Tuesday, March 31, 2020
BiomX Positive Phase 1 Study for Acne
-
Monday, March 30, 2020
A Nose for Coronavirus Detection
-
Wednesday, March 18, 2020
Today's Research is Tomorrow's Viral Threat Defense
-
Tuesday, January 28, 2020
Frontier Tech - Israel's First Deep Tech
-
Thursday, January 9, 2020
Yeda and Deerfield Create Orchard Innovations - $130 Million
-
Monday, January 6, 2020
Yeda and Deerfield Create Orchard Innovations (Hebrew PR)
-
Thursday, March 21, 2019
Korea's Bio-Leaders To Invest $10 Million in Weizmann Institute Anti-Cancer Therapy
-
Sunday, July 8, 2018
Weizmann Institute of Science is Ninth in the World in Research Quality
-
Friday, April 27, 2018
One Patent, Three Drugs // Eli Lilly and Company
-
Monday, January 1, 2018
Gil Granot-Mayer Will Replace Amir Naiberg as CEO of Yeda
-
Tuesday, December 26, 2017
13 of the biggest health breakthroughs in Israel in 2017
-
Thursday, May 5, 2016
Technology transfer trends at the Weizmann Institute of Science
-
Sunday, March 13, 2016
New Options for Prostate Cancer Patients - EAU16 Plenary Session 2
-
Tuesday, February 16, 2016
Karl-Ludwig Kley Receives Weizmann Award in the Sciences and Humanities
-
Tuesday, February 16, 2016
Merck and Weizmann Institute Sign New Framework Agreement on Research Collaboration
-
Monday, January 4, 2016
TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico
-
Wednesday, December 2, 2015
How new fuel tech could drastically reduce CO2 and generate profitable new waste stream
-
Wednesday, December 2, 2015
For Israeli firm, an answer to global warming is blowing in the wind
-
Thursday, February 12, 2015
ImmunArray Ltd announces the Launch of the SLE-key™ Rule Out test
-
Monday, December 1, 2014
The Interferon Connection
-
Wednesday, July 25, 2012
‘3i’ to Develop Microscopes of the Future Based on Weizmann Institute Inventions
-
Thursday, June 7, 2012
Weizmann Institute Solar Technology to Convert Greenhouse Gas into Fuel